122 results on '"Giganti D"'
Search Results
2. Pathobiologic and Metabolic Aspects of Mammary Gland Tumorigenesis by N-Substituted Aryl Compounds
3. Modulation by β-naphthoflavone of ovarian hormone dependent responses in rat uterus and liver in vivo
4. Studies on the transformation of rat embryo cells of low passage by carcinogenic fluorenylhydroxamic acids and their acetate esters
5. 18. Carcinogenicity of N-Arylhydroxamic Acids: A Review of Structure-Activity Relationship
6. Crystal structure of phosphatidyl mannosyltransferase PimA
7. Crystal structure of PvSUB1
8. Structure-function relationships of membrane-associated GT-B glycosyltransferases
9. A model of action for peripheral membrane-associated GT-B glycosyltransferases
10. Three dimensional structure and catalytic mechanism of 6- phosphogluconolactonase from Trypanosoma brucei
11. Aryl Sulfotransferase IV Deficiency in Rat Liver Carcinogenesis Initiated with Diethylnitrosamine and Promoted withN-2-Fluorenylacetamide or Its C-9-Oxidized Metabolites
12. Peroxidative metabolism of carcinogenic N-arylhydroxamic acids: implications for tumorigenesis.
13. Modulations of hepatic gamma-glutamyltranspeptidase and N-hydroxy-N-2-fluorenylacetamide sulfotransferase activities following treatment of rats with a hepatocarcinogenic regimen: effect of partial hepatectomy.
14. N-Hydroxy-2-fluorenylacetamide, an Active Intermediate of the Mammary Carcinogen N-Hydroxy-2-fluorenylbenzenesulfonamide1.
15. DNA Adducts from Nitroreduction of 2,7-Dinitrofluorene, a Mammary Gland Carcinogen, Catalyzed by Rat Liver or Mammary Gland Cytosol
16. Reductions of Nitro and 9-Oxo Groups of Environmental Nitrofluorenes by the Rat Mammary Gland in Vitro
17. Post-initiation treatment of rats with indole-3-carbinol or b-naphthoflavone does not suppress 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis
18. Potent carcinogenicity of 2,7-dinitrofluorene, an environmental pollutant, for the mammary gland of female Sprague-Dawley rats
19. N-Hydroxy-2-fluorenylacetamide, an Active Intermediate of the Mammary Carcinogen N-Hydroxy-2-fluorenylbenzenesulfonamide1
20. Nitroreduction of Nitrated and C-9 Oxidized Fluorenes in Vitro
21. Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver.
22. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans
23. Inhibitory Effect of Disulfiram on Rat Mammary Tumor Induction By N-2-Fluorenylacetamide and on its Metabolic Conversion To N-Hydroxy-N-2-fluorenylacetamide2
24. Systems for the separation of metabolites of the carcinogen, N-2-fluorenylacetamide, by high-performance liquid chromatography
25. Cytochrome c/H2O2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals
26. Lack of Susceptibility of F344 Rats to Mammary Tumor Induction by Topically Applied Fluorenylacetohydroxamic Acids and Their Acetates 2
27. Modifications of Hepatic Microsomal 9-Oxidation ofN-2-Fluorenylacetamide in Response to Gonadectomy and Treatment of Rats with Phenobarbital or Diethylnitrosamine
28. Identification of carcinogenic acetates of fluorenylhydroxamic acids by high-pressure liquid chromatography
29. Malignant Transformation of Rat Embryo Fibroblasts by Carcinogenic Fluorenylhydroxamic Acids In Vitro2
30. Cytochrome c/H 2O 2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals
31. Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine
32. Peroxidative metabolism of carcinogenic N-Arylhydroxamic acids: implications for tumorigenesis
33. Modulations of hepatic delta-glutamyltranspeptidase and N-hydroxy-N-2-fluorenylacetamide sulfotransferase activities following treatment of rats with a hepatocarcinogenic regimen: effect of partial hepatectomy
34. Sex hormone-mediated effects on metabolism of the carcinogen, N-2-fluorenylacetamide ( [formula omitted]), by rat liver
35. Basal oxidation of conserved cysteines modulates cardiac titin stiffness and dynamics.
36. Dissecting the Structural and Chemical Determinants of the "Open-to-Closed" Motion in the Mannosyltransferase PimA from Mycobacteria.
37. Conformational entropy of a single peptide controlled under force governs protease recognition and catalysis.
38. The force-dependent mechanism of DnaK-mediated mechanical folding.
39. Disulfide isomerization reactions in titin immunoglobulin domains enable a mode of protein elasticity.
40. Single-molecule Force Spectroscopy Predicts a Misfolded, Domain-swapped Conformation in human γD-Crystallin Protein.
41. Secondary structure reshuffling modulates glycosyltransferase function at the membrane.
42. A novel Plasmodium-specific prodomain fold regulates the malaria drug target SUB1 subtilase.
43. S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding.
44. Structure-function relationships of membrane-associated GT-B glycosyltransferases.
45. Conformational plasticity of the essential membrane-associated mannosyltransferase PimA from mycobacteria.
46. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
47. Elasticity, structure, and relaxation of extended proteins under force.
48. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.
49. Comparative evaluation of 3D virtual ligand screening methods: impact of the molecular alignment on enrichment.
50. Substrate-induced conformational changes in the essential peripheral membrane-associated mannosyltransferase PimA from mycobacteria: implications for catalysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.